Visual impairment and medication safety: a protocol for a scoping review.
dc.contributor.author | Giles, Sally J; orcid: 0000-0003-1623-6029; email: sally.giles@manchester.ac.uk | |
dc.contributor.author | Panagioti, Maria | |
dc.contributor.author | Riste, Lisa | |
dc.contributor.author | Cheraghi-Sohi, Sudeh | |
dc.contributor.author | Lewis, Penny | |
dc.contributor.author | Adeyemi, Isabel | |
dc.contributor.author | Davies, Karen | |
dc.contributor.author | Morris, Rebecca | |
dc.contributor.author | Phipps, Denham | |
dc.contributor.author | Dickenson, Christine | |
dc.contributor.author | Ashcroft, Darren | |
dc.contributor.author | Sanders, Caroline | |
dc.date.accessioned | 2021-10-18T00:36:44Z | |
dc.date.available | 2021-10-18T00:36:44Z | |
dc.date.issued | 2021-09-15 | |
dc.identifier | https://chesterrep.openrepository.com/bitstream/handle/10034/626121/article.pdf?sequence=2 | |
dc.identifier.citation | Systematic reviews, volume 10, issue 1, page 248 | |
dc.identifier.uri | http://hdl.handle.net/10034/626121 | |
dc.description | From Europe PMC via Jisc Publications Router | |
dc.description | History: ppub 2021-09-01, epub 2021-09-15 | |
dc.description | Publication status: Published | |
dc.description | Funder: National Institute for Health Research | |
dc.description.abstract | <h4>Background</h4>The number of individuals with a visual impairment in the UK was estimated a few years ago to be around 1.8 million. People can be visually impaired from birth, childhood, early adulthood or later in life. Those with visual impairment are subject to health inequities and increased risk for patient safety incidents in comparison to the general population. They are also known to be at an increased risk of experiencing medication errors compared to those without visual impairment. In view of this, this review aims to understand the issues of medication safety for VI people.<h4>Methods/design</h4>Four electronic bibliographic databases will be searched: MEDLINE, Embase, PsycInfo and CINAHL. Our search strategy will include search combinations of two key blocks of terms. Studies will not be excluded based on design. Included studies will be empirical studies. They will include studies that relate to both medication safety and visual impairment. Two reviewers (SG and LR) will screen all the titles and abstracts. SG, LR, RM, SCS and PL will perform study selection and data extraction using standard forms. Disagreements will be resolved through discussion or third party adjudication. Data to be collected will include study characteristics (year, objective, research method, setting, country), participant characteristics (number, age, gender, diagnoses), medication safety incident type and characteristics.<h4>Discussion</h4>The review will summarise the literature relating to medication safety and visual impairment. | |
dc.language | eng | |
dc.rights | Licence for this article: cc by | |
dc.source | essn: 2046-4053 | |
dc.source | nlmid: 101580575 | |
dc.source | issn: 2046-4053 | |
dc.subject | Visual Impairment | |
dc.subject | Medication Safety | |
dc.title | Visual impairment and medication safety: a protocol for a scoping review. | |
dc.type | article | |
dc.date.updated | 2021-10-18T00:36:44Z |